Background. We hypothesized that ephedrine and phenylephrine are equal with respect to uterine and placental haemodynamics and fetal acid-base status after exposure to maternal hypoxaemia and hypotension in a chronic sheep model of increased placental vascular resistance (R UA ).
Ephedrine has been associated with lower umbilical artery pH compared with phenylephrine when used for the prevention or treatment of maternal hypotension during elective Caesarean delivery under spinal anaesthesia in uncomplicated, term pregnancies. [1] [2] [3] [4] The efficacy of prophylactic ephedrine in preventing maternal hypotension seems to be of limited value, 1 5 whereas a combination of ephedrine and phenylephrine or phenylephrine alone may be more effective. 1 6 On the basis of these findings in human pregnancies, phenylephrine has been suggested as the first-line treatment strategy for maternal hypotension. 6 7 Caesarean delivery is frequently performed in placental insufficiency to minimize fetal morbidity and mortality. Phenylephrine has not, however, been studied in human pregnancies complicated by placental insufficiency nor in animal models of increased placental vascular resistance.
We have previously shown that treatment of maternal epidural-induced hypotension with ephedrine or phenylephrine after short-term fetal hypoxaemia in a chronic sheep model with undisturbed placental circulation results in comparable fetal blood gas values and lactate concentrations. 8 In the present randomized study we hypothesized that ephedrine and phenylephrine are equal with respect to uterine and placental haemodynamics and fetal arterial acid-base values and lactate concentrations when administered for epidural-induced hypotension, after a short period of maternal hypoxaemia, in a chronic sheep model of increased placental vascular resistance (R UA ).
Methods
The research protocol was approved by the Animal Care and Use Committee of the University of Oulu. All experiments were performed in accordance with the 'European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes' (Council of Europe 1986) and the European Union Directive ETS 123 (1997).
Animal preparation
Fourteen ewes of Finnish breed with median (range) body weight of 69 (47-95) kg were operated at 110-131 days of singleton or twin gestation (term 145 days). After overnight fasting, the animals were premedicated using i.m. ketamine 2 mg kg À1 and midazolam 0.2 mg kg À1 . General anaesthesia was induced with i.v. propofol 4-7 mg kg À1 and, after tracheal intubation, maintained with isoflurane at an end-tidal concentration of 1-2.5% in an oxygen/air mixture in combination with i.v. boluses of fentanyl as required. Mechanical ventilation was begun with an inhaled oxygen concentration of 40% and a tidal volume of 8-10 ml kg À1 delivered 17 times per minute by a Siemens 730 ventilator (Siemens-Elema AB, Solna, Sweden), and adjusted individually to maintain arterial Po 2 above 11.0 kPa and Pco 2 between 4.5 and 5.4 kPa. Laparotomy was performed and a 6 mm transit-time ultrasonic flow probe (Transonic Systems Inc., Ithaca, NY, USA) was secured around a proximal part of the uterine artery supplying the pregnant uterine horn. Thereafter, the fetal hind limbs and abdomen were exteriorized via a hysterotomy, and 18 G polyurethane catheters were placed into the fetal inferior vena cava and descending aorta via the femoral vein and artery. An incision was made in the fetal abdomen immediately below the umbilical cord insertion and the umbilical arteries were identified. A 4 mm transit-time ultrasonic flow probe (Transonic Systems Inc., Ithaca, NY, USA) was placed around the umbilical arteries and secured to the fetal abdomen. The fetus was then returned to the uterine cavity, the lost amniotic fluid was replaced with 0.9% saline (39 C), and the hysterotomy and laparotomy incisions were closed. In the case of twin gestation, only one fetus was instrumented. All catheters and cables were tunnelled s.c. and exteriorized through a small incision in the ewe's flank. The laparotomy incision was infiltrated with bupivacaine 0.5% (20 ml) to relieve pain during the first postoperative hours. Thereafter, i.m. buprenorphine 0.01 mg kg À1 was administered twice daily throughout the 5 day recovery period. The ewes were given ampicillin 1 g and the fetuses 1 000 000 U of benzyl penicillin daily, and the catheters were flushed with heparinized saline. Fetal acid-base values and uterine (Q UtA ) and placental (Q UA ) volume blood flows were monitored daily.
Experimental protocol
The placenta was embolized on the fourth postoperative day with 45-150 mm microspheres (Contour Emboli, Target Therapeutics, Fremont, CA, USA). A dry volume of 0.25 ml microspheres was suspended in 0.5 ml of albumin 20% and diluted with 10 ml of saline. This solution was injected into the fetal descending aorta via the femoral artery catheter in 1 ml increments every 15 min until fetal arterial oxygen saturation decreased by 30% from the preembolization values.
Experiments were performed 24 h after placental embolization. General anaesthesia was induced using i.v. propofol 4-7 mg kg À1 and maintained throughout the experiment with isoflurane 1-1.5% in an oxygen/air mixture via a tracheal tube. Muscle relaxation was induced with rocuronium 20 mg to facilitate mechanical ventilation. Before the induction of general anaesthesia, 500 ml of hydroxyethyl starch solution was rapidly infused. Thereafter, Ringer's solution was infused at a fixed rate of 200 ml h À1 . A thermodilution catheter (Criticath SP5107H, Becton Dickinson, Sandy, UT, USA) was introduced through a jugular vein introducer placed during the primary operation, and a 16 G polyurethane catheter was placed into the descending aorta of the ewe via a femoral artery. A 19 G epidural catheter was inserted into the epidural space at the lumbosacral junction or, if this approach failed, at the lowest lumbar interspace. The ewe was then placed supine with right lateral tilt.
A 30 min stabilization period was allowed to adjust mechanical ventilation to maintain arterial Po 2 above 11.0 kPa and Pco 2 between 4.5 and 5.4 kPa. Thereafter, baseline measurements were obtained (phase 1). At time zero, acute maternal and fetal hypoxaemia were induced by replacing oxygen with medical air in the rebreathing circuit (phase 2). At 15 min, the maternal inhaled oxygen concentration was returned to baseline, and the ewe and fetus were allowed to recover from hypoxaemia (phase 3). At 30 min, the ewe was given 5 ml of bupivacaine 0.5% through the epidural catheter as a test dose. Thereafter, bupivacaine 0.5% was administered to a total dose of 0.3 mg kg À1 over a 2 min period. Hypotension to at least a 30% decrease in maternal systolic arterial blood pressure (SAP) was allowed to develop (phase 4). At 45 min, the ewes were randomized into the ephedrine or phenylephrine group by picking a sealed envelope. During the next 30 min, 5 mg boluses of ephedrine or 0.1 mg boluses of phenylephrine were administered to maintain a maternal SAP of at least 90% of the baseline (phase 5). At 75 min, the ewe and the fetus were killed with an i.v. overdose of pentobarbital.
The maternal arterial catheter and the pulmonary artery catheter were attached to disposable pressure transducers (DT-XX, Ohmeda, Hatfield, UK) to measure maternal arterial, central venous (CVP), and pulmonary arterial pressures. The fetal arterial and venous catheters were connected to reusable transducers (Biopac Systems Inc., Santa Barbara, CA, USA) for pressure measurements. Maternal and fetal mean arterial pressures (MAPs) were computed arithmetically, and heart rates (HRs) were computed from the arterial waveforms. The perivascular flow probes were attached to a flow meter (T206, Transonic Systems Inc., Ithaca, NY, USA) to measure Q UtA and Q UA . Uterine vascular resistance (R UtA ) and R UA were computed by dividing maternal and fetal MAPs by Q UtA and Q UA , respectively. All these variables were recorded continuously at a 100 Hz sampling rate using a polygraph (UIM100A, Biopac Systems Inc., Santa Barbara, CA, USA) and computerized data acquisition software (Acqknowledge v. 3.5.7 for Windows, Biopac Systems Inc., Santa Barbara, CA, USA). Recordings were later analysed in 1 min periods and the median value of the 6000 measurements per variable was chosen to represent a particular minute. Means of the last 5 min of phases 1, 2, 3 and 4 and the second to last 5 min of phase 5 were considered representative for each phase and used in the analyses.
Cardiac output (CO) was measured in triplicate at the end of each phase with the thermodilution catheter and a Datex A/S3 monitor (Datex Inc., Espoo, Finland). Pulmonary capillary wedge pressure (PCWP) and systemic vascular resistance (SVR) were obtained with the CO measurements. Cardiac index (CI) and SVR index (SVRI) were derived from CO and SVR. Maternal and fetal arterial blood samples were drawn at the end of each phase and immediately analysed for acid-base values (39 C). Maternal and fetal lactate concentrations were obtained at the end of phases 1, 4 and 5. Doppler ultrasonographic recordings (Acuson Sequoia 512, Mountain View, CA, USA) from proximal uterine artery and umbilical artery were obtained at the end of each phase. The mean values for uterine artery (PI UtA ) and umbilical artery (PI UA ) pulsatility indices [PI=(peak systolic velocityÀend diastolic velocity)/time-averaged maximum velocity over the cardiac cycle] were derived from three consecutive cardiac cycles.
The data were analysed using SPSS 11.5 for Windows (SPSS Inc., Chicago, IL, USA). Univariate intergroup comparisons were made using Student's t-test if the data were normally distributed or, otherwise, the Mann-Whitney U-test was chosen. For parameters that were continuously or repeatedly monitored, analysis of variance (ANOVA) for repeated measurements was used to evaluate whether there were changes in measurements over time (within-subjects P), or differences between the groups (between-subjects P), or differences in changes over time between the groups (interaction P). The Bonferroni adjustment for multiple comparisons was applied to assess differences at each phase vs baseline (pairwise P). A two-tailed P-value of 0.05 or less was selected as the level of statistical significance. The data are presented as mean (standard deviation, SD), median [range], or mean with 95% confidence intervals.
Results
Seven ewes in the ephedrine group and six in the phenylephrine group were included in the analyses. One ewe was excluded before randomization, because Q UA had decreased by 76% from baseline at the end of phase 4 and the fetus was severely acidotic.
The mean weights of the ewes and fetuses, the gestational age, and the dose of embolization particles were comparable between the groups (Table 1) . Maternal end-tidal isoflurane concentrations were comparable between the groups during the entire experiment (data not shown). The median total dose of vasopressor given was 30.0 (range 20.0-50.0) mg in the ephedrine group and 1.6 (0.9-1.8) mg in the phenylephrine group. Mean Q UtA measured awake before placental embolization was comparable to mean Q UtA during general anaesthesia at baseline [495 (SD 296) vs 517 (209) ml min À1 ; P=0.6]. Compared with preembolization values, the mean Q UA measured at baseline 24 h after embolization had decreased from 247 (87) to 189 (85) ml min À1 (P=0.004). Prerandomization comparisons (Tables 2 and 3 ) confirmed that there were no significant differences between the groups before vasopressor administration, except in maternal SVRI, and no significant differences in changes over time between the groups, except in maternal pH. However, maternal pH and SVRI values were within the normal range in both vasopressor groups. As randomization was performed after phase 4, the changes from baseline (phase 1) during phases 2 (hypoxaemia), 3 (recovery from hypoxaemia), and 4 (hypotension) are reported with the two groups combined. During phase 2, maternal and fetal Po 2 values and Q UA decreased from baseline. At the end of phase 4, maternal MAP, HR, CI, Q UtA , and Pco 2 , and fetal pH, Po 2 and BE were lower and R UtA , PI UtA , R UA , and fetal lactate concentration higher than at baseline (Tables 2 and 3 ). During vasopressor administration, when compared with baseline, the changes over time between the groups were different in maternal HR, CVP, CI and pH, Q UtA , R UtA , Q UA , and R UA (Tables 4 and 5) .
Maternal MAP and CI, Q UtA , R UtA , PI UtA , and fetal Po 2 and R UA returned to baseline during administration of ephedrine (Tables 4 and 5 ), whereas maternal HR increased above baseline values. Fetal pH, BE, and lactate concentration remained at the hypotensive level. There were two cases of a fetal pH <7.20, the values being 7.08 and 7.17 with corresponding base deficits of 9.0 and 7.6 mmol litre À1 , respectively. In two fetuses, lactate concentration was >4.8 mmol litre À1 . Maternal MAP returned to baseline values and CVP increased to beyond baseline during administration of phenylephrine. HR and CI remained lower than baseline (Tables 4 and 5 
Discussion
The present study was designed to investigate the effects of ephedrine and phenylephrine on uterine and placental haemodynamics and fetal acid-base values and lactate concentrations after exposure to maternal hypoxaemia and hypotension in a chronic sheep model with placental embolization and increased R UA . Previously, it has been shown in fetal sheep that placental embolization decreases Q UA and increases R UA leading to fetal hypoxaemia. 9 10 Accordingly, Q UA before embolization in this study was significantly higher than during the baseline measurements 24 h after placental embolization. Compared with our previous series of non-embolized sheep fetuses of similar gestational age, 8 fetuses with placental embolization had 110% higher R UA and 35% lower fetal Po 2 at baseline. In previous studies on fetal sheep with normal placental function Q UA increased during acute fetal hypoxaemia induced by administration of a low-oxygen gas mixture to the ewe or restriction of uterine blood flow. 11 12 In the present study, Q UA decreased or R UA increased when fetal oxygenation was further compromised by maternal hypoxaemia or hypotension. This indicates that the degree of placental embolization was sufficient to modify physiologic responses to fetal hypoxaemia.
After vasopressor administration, placental haemodynamics returned to baseline with ephedrine but not with phenylephrine. Recent in vitro observations on human umbilical arteries have shown concentration-dependent contractions with phenylephrine 13 and no contraction with ephedrine at the concentrations capable of producing significant effects on atrial and anococcygeal tissues.
14 Therefore, we propose that the transplacental passage of phenylephrine and its constrictive effect on placental circulation explains the elevated R UA in the phenylephrine group. This is also supported by our previous observations on non-embolized fetal sheep in which Q UA decreased after prolonged phenylephrine administration. 8 During maternal hypotension, Q UtA decreased and R UtA increased and were restored to baseline by ephedrine but not by phenylephrine. These observations are consistent with the pharmacological effects of the two drugs. Both ephedrine and phenylephrine are capable of producing uterine arterial vasoconstriction, [15] [16] [17] [18] [19] which is mediated by a1-adrenoceptors in human and ovine uterine arteries. 18 19 The contractile response of the uterine artery to both ephedrine and phenylephrine is attenuated in pregnancy as a result of increased nitric oxide activity. 16 17 It has been suggested, however, that ephedrine constricts systemic vessels more selectively than the uterine artery during pregnancy when compared with other vasopressors. 15 In addition, it is likely that ephedrine increased CI more than phenylephrine because of its b-adrenergic function. After placental embolization, PI UA was 50% higher than in our previous study on non-embolized fetal sheep. 8 Although the use of umbilical artery Doppler velocimetry has been validated in sheep, 20 the changes in placental circulation during maternal hypoxaemia, hypotension, and phenylephrine administration were not reflected in PI UA . In accordance with the invasive observations on R UtA , PI UtA increased during hypotension and was normalized by ephedrine but not phenylephrine. With phenylephrine, PI UtA decreased from hypotensive values but R UtA remained at the hypotensive level. These results further support earlier findings that PI UtA and PI UA do not directly reflect changes in R UtA and R UA caused by vasoactive drugs, 8 9 or changes in fetal oxygenation.
In the newborn, an umbilical artery pH of less than 7.00-7.10 and a base deficit of more than 12.0 mmol litre
À1
have been suggested as thresholds of significant metabolic acidosis associated with major neonatal morbidity. 21 22 In this study, fetal blood gas analyses showed no differences between the two vasopressor groups. Both vasopressors corrected the decrease in fetal Po 2 secondary to maternal hypotension. In contrast to our previous study on nonembolized fetuses, 8 fetal pH decreased during maternal hypotension. Fetal pH, Pco 2 , and BE did not further deteriorate from hypotensive values during treatment with either of the two vasopressors. It has been suggested that the lactate concentration of human fetal scalp blood is more sensitive than pH in predicting neonatal neurological disability. 23 Fetal scalp blood lactate concentrations are known to correlate well with those in neonatal arterial and venous cord blood. 24 In the present study, after vasopressor administration, fetal arterial lactate concentration was high in both vasopressor groups. When compared with hypotensive values, lactate concentrations remained unchanged in the ephedrine group. This suggests that the lactic acidosis in the ephedrine group was attributable to the period of maternal hypotension and not to ephedrine itself. During the administration of phenylephrine, fetal lactate concentrations further increased from hypotensive values. In five out of six fetuses in the phenylephrine group, lactate concentration exceeded 4.8 mmol litre À1 , which is the suggested cutoff for human fetal scalp blood lactate concentrations as an indicator of asphyxia. 23 Our results may reflect impaired clearance of lactate from the fetus as a result of reduced placental perfusion with phenylephrine.
Recent studies on human fetuses have shown higher umbilical artery pH with phenylephrine than ephedrine. [1] [2] [3] [4] In a study comparing different prophylactic phenylephrine infusion regimens in humans, umbilical artery pH was highest when the aim was to maintain maternal blood pressure at 100% of baseline. 25 In addition to an increase in placental vascular resistance, the fetuses in the present study were exposed to maternal hypoxaemia and hypotension to challenge fetal compensatory mechanisms before vasopressor administration. It has been suggested that increased fetal metabolic rate secondary to b-adrenergic stimulation is the mechanism for the lower pH with ephedrine. 2 3 Indeed, infusion of the b-adrenergic agonist isoprotenol increases oxygen consumption and blood glucose and lactate concentrations and decreases pH in fetal sheep. 26 In addition, human neonatal norepinephrine concentrations are higher after ephedrine than after phenylephrine. 27 Norepinephrine is released into the fetal circulation during stress. 28 We propose that endogenous norepinephrine concentrations in our compromised near-term fetuses were elevated to such an extent that the additional b-adrenergic stimulation caused by ephedrine was not sufficient to further increase fetal metabolic rate.
There are several limitations to the applicability of our results to humans. First, there are species differences in a-and b-adrenergic receptor distribution, possibly resulting in varying vascular responses to vasopressors. This may explain why the concentrations of vasopressor solutions we chose on the basis of our clinical experience were not equipotent. 29 However, the doses of ephedrine and phenylephrine used in the present study were comparable to those in recent clinical studies on human pregnancies. 3 6 25 Second, there may be species differences in the placental transfer of vasopressors. The countercurrent blood flow pattern that is partly present in sheep placenta may suggest an enhanced placental transfer of vasopressors in sheep compared with humans. 30 The diffusion barrier between uterine and umbilical blood compartments is, however, thicker in the synepitheliochorial placenta of sheep compared with the haemomonochorial placenta of humans. 30 Third, for ethical reasons and to allow a supine position, the experiments were performed in anaesthetized and mechanically ventilated animals. Although a similar induction of general anaesthesia had no significant effect on Q UtA or Q UA in our previous study, 8 the combination of general and regional anaesthesia may have caused maternal cardiac depression and excessive vasodilation combined with reduced venous return. This may be the cause of maternal bradycardia during hypotension, 31 which probably impaired the restoration of maternal CI and, thus, Q UtA with phenylephrine. However, high-thoracic epidural anaesthesia alone can induce this type of change in maternal haemodynamics. 31 We conclude that in near-term fetal sheep with increased placental vascular resistance, the effects of ephedrine on uterine and placental circulations after exposure to maternal hypoxaemia and hypotension were more favourable than those of phenylephrine. Although there were no significant differences in fetal acid-base values between the ephedrine and phenylephrine groups, fetal lactate concentrations increased further from hypotensive values when maternal hypotension was treated with phenylephrine.
